Piper Sandler analyst David Westenberg raised the firm’s price target on Zoetis (ZTS) to $210 from $205 following quarterly results. The firm keeps an Overweight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZTS:
- Zoetis price target lowered to $170 from $189 at UBS
- Zoetis: Strong Financial Performance and Growth Potential Justify Buy Rating
- Zoetis Reports Modest Revenue Growth in Q1 2025
- Zoetis Earnings Call: Strong Growth Amid Challenges
- Zoetis: Buy Rating Affirmed Amid Strong Companion Animal Growth and Optimistic Outlook